Literature DB >> 32022254

Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes.

Masahiro Ono1.   

Abstract

The transcription factor Foxp3 controls the differentiation and function of regulatory T-cells (Treg). Studies in the past decades identified numerous Foxp3-interacting protein partners. However, it is still not clear how Foxp3 produces the Treg-type transcriptomic landscape through cooperating with its partners. Here I show the current understanding of how Foxp3 transcription factor complexes regulate the differentiation, maintenance and functional maturation of Treg. Importantly, T-cell receptor (TCR) signalling plays central roles in Treg differentiation and Foxp3-mediated gene regulation. Differentiating Treg will have recognized their cognate antigens and received TCR signals before initiating Foxp3 transcription, which is triggered by TCR-induced transcription factors including NFAT, AP-1 and NF-κB. Once expressed, Foxp3 seizes TCR signal-induced transcriptional and epigenetic mechanisms through interacting with AML1/Runx1 and NFAT. Thus, Foxp3 modifies gene expression dynamics of TCR-induced genes, which constitute cardinal mechanisms for Treg-mediated immune suppression. Next, I discuss the following key topics, proposing new mechanistic models for Foxp3-mediated gene regulation: (i) how Foxp3 transcription is induced and maintained by the Foxp3-inducing enhanceosome and the Foxp3 autoregulatory transcription factor complex; (ii) molecular mechanisms for effector Treg differentiation (i.e. Treg maturation); (iii) how Foxp3 activates or represses its target genes through recruiting coactivators and corepressors; (iv) the 'decision-making' Foxp3-containing transcription factor complex for Th17 and Treg differentiation; and (v) the roles of post-translational modification in Foxp3 regulation. Thus, this article provides cutting-edge understanding of molecular biology of Foxp3 and Treg, integrating findings by biochemical and genomic studies.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  AML1/Runx1; Foxp3; TCR signalling; protein-protein interaction; regulatory T-cells; transcription factor

Mesh:

Substances:

Year:  2020        PMID: 32022254      PMCID: PMC7160660          DOI: 10.1111/imm.13178

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  155 in total

1.  Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine.

Authors:  Kwang Soon Kim; Sung-Wook Hong; Daehee Han; Jaeu Yi; Jisun Jung; Bo-Gie Yang; Jun Young Lee; Minji Lee; Charles D Surh
Journal:  Science       Date:  2016-01-28       Impact factor: 47.728

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

3.  The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses.

Authors:  Lucy S K Walker; David M Sansom
Journal:  Nat Rev Immunol       Date:  2011-11-25       Impact factor: 53.106

4.  Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1.

Authors:  Eric V Dang; Joseph Barbi; Huang-Yu Yang; Dilini Jinasena; Hong Yu; Ying Zheng; Zachary Bordman; Juan Fu; Young Kim; Hung-Rong Yen; Weibo Luo; Karen Zeller; Larissa Shimoda; Suzanne L Topalian; Gregg L Semenza; Chi V Dang; Drew M Pardoll; Fan Pan
Journal:  Cell       Date:  2011-08-25       Impact factor: 41.582

5.  Runt-related Transcription Factor 1 (RUNX1) Binds to p50 in Macrophages and Enhances TLR4-triggered Inflammation and Septic Shock.

Authors:  Mao-Cai Luo; Si-Yuan Zhou; Dan-Ying Feng; Jun Xiao; Wei-Yun Li; Chun-Di Xu; Hong-Yan Wang; Tong Zhou
Journal:  J Biol Chem       Date:  2016-08-29       Impact factor: 5.157

6.  c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells.

Authors:  Iwao Isomura; Stephanie Palmer; Raelene J Grumont; Karen Bunting; Gerard Hoyne; Nancy Wilkinson; Ashish Banerjee; Anna Proietto; Raffi Gugasyan; Li Wu; Wu Li; Alice McNally; Raymond J Steptoe; Ranjeny Thomas; M Frances Shannon; Steve Gerondakis
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

Review 7.  RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.

Authors:  C P Koh; C Q Wang; C E L Ng; Y Ito; M Araki; V Tergaonkar; G Huang; M Osato
Journal:  Leukemia       Date:  2013-07-02       Impact factor: 11.528

8.  FOXP3 controls regulatory T cell function through cooperation with NFAT.

Authors:  Yongqing Wu; Madhuri Borde; Vigo Heissmeyer; Markus Feuerer; Ariya D Lapan; James C Stroud; Darren L Bates; Liang Guo; Aidong Han; Steven F Ziegler; Diane Mathis; Christophe Benoist; Lin Chen; Anjana Rao
Journal:  Cell       Date:  2006-07-28       Impact factor: 41.582

9.  Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells.

Authors:  Dipayan Rudra; Takeshi Egawa; Mark M W Chong; Piper Treuting; Dan R Littman; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2009-09-20       Impact factor: 25.606

10.  Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus.

Authors:  Yongqiang Feng; Aaron Arvey; Takatoshi Chinen; Joris van der Veeken; Georg Gasteiger; Alexander Y Rudensky
Journal:  Cell       Date:  2014-08-14       Impact factor: 41.582

View more
  43 in total

Review 1.  Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+ regulatory T cells.

Authors:  Mark D Mannie; Kayla B DeOca; Alexander G Bastian; Cody D Moorman
Journal:  Cell Immunol       Date:  2020-07-15       Impact factor: 4.868

Review 2.  Sex disparities matter in cancer development and therapy.

Authors:  Sue Haupt; Franco Caramia; Sabra L Klein; Joshua B Rubin; Ygal Haupt
Journal:  Nat Rev Cancer       Date:  2021-04-20       Impact factor: 60.716

3.  The Immunogenetics of Alopecia areata.

Authors:  Fateme Rajabi; Fahimeh Abdollahimajd; Navid Jabalameli; Mansour Nassiri Kashani; Alireza Firooz
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Regulatory T-Cell Phenotyping Using CyTOF.

Authors:  Hugo Barcenilla; Mikael Pihl; Florence Sjögren; Louise Magnusson; Rosaura Casas
Journal:  Methods Mol Biol       Date:  2023

5.  RUNX inhibitor suppresses graft-versus-host disease through targeting RUNX-NFATC2 axis.

Authors:  Hirohito Kubota; Tatsuya Masuda; Mina Noura; Kana Furuichi; Hidemasa Matsuo; Masahiro Hirata; Tatsuki R Kataoka; Hidefumi Hiramatsu; Takahiro Yasumi; Tatsutoshi Nakahata; Yoichi Imai; Junko Takita; Souichi Adachi; Hiroshi Sugiyama; Yasuhiko Kamikubo
Journal:  EJHaem       Date:  2021-05-19

6.  Effect of systemic steroid therapy in Graves' orbitopathy on regulatory T cells and Th17/Treg ratio.

Authors:  M Siomkajło; Ł Mizera; D Szymczak; K Kolačkov; J Grzegrzółka; M Bolanowski; J Daroszewski
Journal:  J Endocrinol Invest       Date:  2021-04-17       Impact factor: 4.256

7.  Teaching tolerance: Diverse cellular interactions enable healthy maturation.

Authors:  Annika Frede; Simon Milling
Journal:  Immunology       Date:  2021-07       Impact factor: 7.215

Review 8.  Mechanisms of exTreg induction.

Authors:  Vikas Saxena; Ram Lakhan; Jegan Iyyathurai; Jonathan S Bromberg
Journal:  Eur J Immunol       Date:  2021-05-27       Impact factor: 6.688

9.  Ex Vivo-Induced Bone Marrow-Derived Myeloid Suppressor Cells Prevent Corneal Allograft Rejection in Mice.

Authors:  Jun Zhu; Takenori Inomata; Keiichi Fujimoto; Koichiro Uchida; Kenta Fujio; Ken Nagino; Maria Miura; Naoko Negishi; Yuichi Okumura; Yasutsugu Akasaki; Kunihiko Hirosawa; Mizu Kuwahara; Atsuko Eguchi; Hurramhon Shokirova; Ai Yanagawa; Akie Midorikawa-Inomata; Akira Murakami
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-06-01       Impact factor: 4.799

10.  Differential transcriptional and functional properties of regulatory T cells in HIV-infected individuals on antiretroviral therapy and long-term non-progressors.

Authors:  Shima Shahbaz; Juan Jovel; Shokrollah Elahi
Journal:  Clin Transl Immunology       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.